Literature DB >> 32111712

Clinical conundrum: status epilepticus culminating into acute dystonia myoclonus.

Madhuri Laxman Khilari1, Praveen Kumar Sharma2.   

Abstract

A 7-year-old child who suffered from symptomatic focal epilepsy as a sequel to perinatal hypoxia used to have frequent seizures. This time she developed prolonged status epilepticus lasting for over 5 hours. She received a treatment in the form of intravenous midazolam and reinitiation of sodium valproate and clobazam that were discontinued previously. Seizures were controlled over a couple of hours, but she remained unresponsive. Later, she developed acute onset dystonia (day 3 post-status epilepticus) and also myoclonic jerks. She presented to us after 3 weeks of onset of these complaints and we considered hypoxic encephalopathy resulting from prolonged status epilepticus or acute encephalitis or non-convulsive status epilepticus. However, acute onset dystonia and periodicity of myoclonic jerks were pointers against it, and on evaluation, she was diagnosed with atypical fulminant subacute sclerosing panencephalitis (SSPE). Knowing the atypical presentations of SSPE is important in planning management and prognostication. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epilepsy and seizures; infection (neurology); neuroimaging

Mesh:

Year:  2020        PMID: 32111712      PMCID: PMC7050353          DOI: 10.1136/bcr-2019-233397

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  30 in total

1.  The management of status epilepticus.

Authors:  S Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

2.  The electroencephalogram in diffuse encephalopathies; significance of periodic synchronous discharges.

Authors:  S LESSE; P F HOEFER; J H AUSTIN
Journal:  AMA Arch Neurol Psychiatry       Date:  1958-04

3.  MR imaging, diffusion-weighted imaging and MR spectroscopy findings in acute rapidly progressive subacute sclerosing panencephalitis.

Authors:  Kader Karli Oguz; Asli Celebi; Banu Anlar
Journal:  Brain Dev       Date:  2006-11-13       Impact factor: 1.961

Review 4.  Subacute sclerosing panencephalitis. Current status.

Authors:  P R Dyken
Journal:  Neurol Clin       Date:  1985-02       Impact factor: 3.806

5.  Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients.

Authors:  C E Jones; P R Dyken; P R Huttenlocher; J T Jabbour; K W Maxwell
Journal:  Lancet       Date:  1982-05-08       Impact factor: 79.321

6.  Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis.

Authors:  A Tomoda; S Shiraishi; M Hosoya; A Hamada; T Miike
Journal:  Pediatr Neurol       Date:  2001-01       Impact factor: 3.372

7.  Electroencephalographic Findings in Posthypoxic Myoclonus.

Authors:  J C van Zijl; M Beudel; H J vd Hoeven; F Lange; M A J Tijssen; J W J Elting
Journal:  J Intensive Care Med       Date:  2015-02-10       Impact factor: 3.510

8.  Subacute sclerosing panencephalitis: remission after treatment with intraventricular interferon.

Authors:  H S Panitch; J Gomez-Plascencia; F H Norris; K Cantell; R A Smith
Journal:  Neurology       Date:  1986-04       Impact factor: 9.910

Review 9.  Pediatric Anti-N-Methyl-d-Aspartate Receptor Encephalitis: A Review with Pooled Analysis and Critical Care Emphasis.

Authors:  Kenneth E Remy; Jason W Custer; Joshua Cappell; Cortney B Foster; Nan A Garber; L Kyle Walker; Liliana Simon; Dayanand Bagdure
Journal:  Front Pediatr       Date:  2017-11-24       Impact factor: 3.418

10.  Atypical magnetic resonance imaging features in subacute sclerosing panencephalitis.

Authors:  Biplab Das; Manoj Kumar Goyal; Manish Modi; Sahil Mehta; Sudheer Chakravarthi; Vivek Lal; Sameer Vyas
Journal:  Ann Indian Acad Neurol       Date:  2016 Apr-Jun       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.